Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exp

Xu, Guozhang; Liu, Zhijie; Wang, Xinkang; Lu, Tianbao; DesJarlais, Renee L.; Thieu, Tho; Zhang, Jing; Devine, Zheng Huang; Du, Fuyong; Li, Qiu; Milligan, Cynthia M.; Shaffer, Paul; Cedervall, Peder E.; Spurlino, John C.; Stratton, Christopher F.; Pietrak, Beth; Szewczuk, Lawrence M.; Wong, Victoria; Steele, Ruth A.; Bruinzeel, Wouter; Chintala, Madhu; Silva, Jose; Gaul, Michael D.; Macielag, Mark J.; Nargund, Ravi

doi:10.1021/acs.jmedchem.2c00442

Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exp

Journal Article · 01 July 2022 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.2c00442· OSTI ID:1900810

Xu, Guozhang; Liu, Zhijie; Wang, Xinkang; Lu, Tianbao; DesJarlais, Renee L.; Thieu, Tho; Zhang, Jing; Devine, Zheng Huang; Du, Fuyong; Li, Qiu; Milligan, Cynthia M.; Shaffer, Paul; Cedervall, Peder E.; Spurlino, John C.; Stratton, Christopher F.; Pietrak, Beth; Szewczuk, Lawrence M.; Wong, Victoria; Steele, Ruth A.; Bruinzeel, Wouter more »

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1900810

Journal Information:: J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (15) Vol. 65

Country of Publication:: United States

Language:: ENGLISH

References (59)

Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury Norman, Bryan H.; Fisher, Matthew J.; Schiffler, Matthew A. Journal of Medicinal Chemistry, Vol. 61, Issue 5 https://doi.org/10.1021/acs.jmedchem.7b01806	journal	February 2018
Factor XIa inhibitors: A review of the patent literature Al-Horani, Rami A.; Desai, Umesh R. Expert Opinion on Therapeutic Patents, Vol. 26, Issue 3 https://doi.org/10.1517/13543776.2016.1154045	journal	February 2016
Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups Corte, James R.; Pinto, Donald J. P.; Fang, Tianan Journal of Medicinal Chemistry, Vol. 63, Issue 2 https://doi.org/10.1021/acs.jmedchem.9b01768	journal	December 2019
How Significant Are Unusual Protein–Ligand Interactions? Insights from Database Mining Kuhn, Bernd; Gilberg, Erik; Taylor, Robin Journal of Medicinal Chemistry, Vol. 62, Issue 22 https://doi.org/10.1021/acs.jmedchem.9b01545	journal	November 2019
Metabolism and Bioactivation: It’s Time to Expect the Unexpected Driscoll, James P.; Sadlowski, Corinne M.; Shah, Nina R. Journal of Medicinal Chemistry, Vol. 63, Issue 12 https://doi.org/10.1021/acs.jmedchem.0c00026	journal	April 2020
pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery Varma, Manthena V.; Gardner, Iain; Steyn, Stefanus J. Molecular Pharmaceutics, Vol. 9, Issue 5 https://doi.org/10.1021/mp2004912	journal	April 2012
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present) Al-Horani, Rami A. Expert Opinion on Therapeutic Patents, Vol. 30, Issue 1 https://doi.org/10.1080/13543776.2020.1705783	journal	December 2019
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study Friberg, Leif; Rosenqvist, Mårten; Lip, Gregory Y. H. Circulation, Vol. 125, Issue 19 https://doi.org/10.1161/CIRCULATIONAHA.111.055079	journal	May 2012
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis Salomon, Ophira; Steinberg, David; Zucker, Michal Thrombosis and Haemostasis, Vol. 105, Issue 02 https://doi.org/10.1160/TH10-05-0307	journal	January 2011
Halogen bonds in biological molecules Auffinger, P.; Hays, F. A.; Westhof, E. Proceedings of the National Academy of Sciences, Vol. 101, Issue 48 https://doi.org/10.1073/pnas.0407607101	journal	November 2004
The Protein Data Bank: a historical perspective Berman, Helen M. Acta Crystallographica Section A Foundations of Crystallography, Vol. 64, Issue 1 https://doi.org/10.1107/S0108767307035623	journal	December 2007
Carbon-Oxygen Hydrogen Bonding in Biological Structure and Function Horowitz, Scott; Trievel, Raymond C. Journal of Biological Chemistry, Vol. 287, Issue 50 https://doi.org/10.1074/jbc.R112.418574	journal	October 2012
Global Burden of Thrombosis Wendelboe, Aaron M.; Raskob, Gary E. Circulation Research, Vol. 118, Issue 9 https://doi.org/10.1161/CIRCRESAHA.115.306841	journal	April 2016
New Oral Anticoagulants in Nonvalvular Atrial Fibrillation Urooj, Fatima; Kulkarni, Abhishek; Stapleton, Dwight Clinical Cardiology, Vol. 39, Issue 12 https://doi.org/10.1002/clc.22582	journal	October 2016
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy Dilger, Andrew K.; Pabbisetty, Kumar B.; Corte, James R. Journal of Medicinal Chemistry, Vol. 65, Issue 3 https://doi.org/10.1021/acs.jmedchem.1c00613	journal	September 2021
Computer Modeling of Halogen Bonds and Other σ-Hole Interactions Kolář, Michal H.; Hobza, Pavel Chemical Reviews, Vol. 116, Issue 9 https://doi.org/10.1021/acs.chemrev.5b00560	journal	February 2016
Discovery of the Novel Antithrombotic Agent 5-Chloro- N -({(5 S )-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): An Oral, Direct Factor Xa Inhibitor Roehrig, Susanne; Straub, Alexander; Pohlmann, Jens Journal of Medicinal Chemistry, Vol. 48, Issue 19 https://doi.org/10.1021/jm050101d	journal	September 2005
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach Lorthiois, Edwige; Roache, James; Barnes-Seeman, David Journal of Medicinal Chemistry, Vol. 63, Issue 15 https://doi.org/10.1021/acs.jmedchem.0c00279	journal	June 2020
Anticoagulation in chronic kidney disease patients--the practical aspects Hughes, S.; Szeki, I.; Nash, M. J. Clinical Kidney Journal, Vol. 7, Issue 5 https://doi.org/10.1093/ckj/sfu080	journal	August 2014
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? Alamneh, Endalkachew A.; Chalmers, Leanne; Bereznicki, Luke R. American Journal of Cardiovascular Drugs, Vol. 16, Issue 3 https://doi.org/10.1007/s40256-016-0161-8	journal	February 2016
Oxidation of organonitrogen compounds by the methyltrioxorhenium-hydrogen peroxide system Murray, Robert W.; Iyanar, Kaliappan; Chen, Jianxin Tetrahedron Letters, Vol. 37, Issue 6 https://doi.org/10.1016/0040-4039(95)02326-7	journal	February 1996
Overview of the New Oral Anticoagulants: Opportunities and Challenges Yeh, Calvin H.; Hogg, Kerstin; Weitz, Jeffrey I. Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35, Issue 5 https://doi.org/10.1161/ATVBAHA.115.303397	journal	May 2015
Rapid detection and characterization of minor reactive metabolites using stable-isotope trapping in combination with tandem mass spectrometry Yan, Zhengyin; Maher, Noureddine; Torres, Rhoda Rapid Communications in Mass Spectrometry, Vol. 19, Issue 22 https://doi.org/10.1002/rcm.2195	journal	January 2005
Methyl Effects on Protein–Ligand Binding Leung, Cheryl S.; Leung, Siegfried S. F.; Tirado-Rives, Julian Journal of Medicinal Chemistry, Vol. 55, Issue 9 https://doi.org/10.1021/jm3003697	journal	April 2012
Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P. Journal of Medicinal Chemistry, Vol. 49, Issue 21 https://doi.org/10.1021/jm051256o	journal	October 2006
Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events Preis, Meir; Hirsch, Julianna; Kotler, Antonio Blood, Vol. 129, Issue 9 https://doi.org/10.1182/blood-2016-09-742262	journal	March 2017
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI Kearney, Katherine J.; Butler, Juliet; Posada, Olga M. Proceedings of the National Academy of Sciences, Vol. 118, Issue 3 https://doi.org/10.1073/pnas.2014810118	journal	January 2021
Oral Anticoagulant Therapy Ageno, Walter; Gallus, Alexander S.; Wittkowsky, Ann Chest, Vol. 141, Issue 2 https://doi.org/10.1378/chest.11-2292	journal	February 2012
Antithrombotic Agents Chan, Noel C.; Weitz, Jeffrey I. Circulation Research, Vol. 124, Issue 3 https://doi.org/10.1161/CIRCRESAHA.118.313155	journal	February 2019
Thrombosis Raskob, G. E.; Angchaisuksiri, P.; Blanco, A. N. Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 34, Issue 11 https://doi.org/10.1161/ATVBAHA.114.304488	journal	November 2014
Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1 H -pyrazolo[3,4- c ]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa Pinto, Donald J. P.; Orwat, Michael J.; Koch, Stephanie Journal of Medicinal Chemistry, Vol. 50, Issue 22 https://doi.org/10.1021/jm070245n	journal	November 2007
Contribution of Explicit Solvent Effects to the Binding Affinity of Small-Molecule Inhibitors in Blood Coagulation Factor Serine Proteases Abel, Robert; Salam, Noeris K.; Shelley, John ChemMedChem, Vol. 6, Issue 6 https://doi.org/10.1002/cmdc.201000533	journal	April 2011
Factor XI and contact activation as targets for antithrombotic therapy Gailani, D.; Bane, C. E.; Gruber, A. Journal of Thrombosis and Haemostasis, Vol. 13, Issue 8 https://doi.org/10.1111/jth.13005	journal	June 2015
Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding Abel, Robert; Young, Tom; Farid, Ramy Journal of the American Chemical Society, Vol. 130, Issue 9 https://doi.org/10.1021/ja0771033	journal	March 2008
Phenylimidazoles as Potent and Selective Inhibitors of Coagulation Factor XIa with in Vivo Antithrombotic Activity Hangeland, Jon J.; Friends, Todd J.; Rossi, Karen A. Journal of Medicinal Chemistry, Vol. 57, Issue 23 https://doi.org/10.1021/jm5010607	journal	November 2014
Motifs for molecular recognition exploiting hydrophobic enclosure in protein–ligand binding Young, Tom; Abel, Robert; Kim, Byungchan Proceedings of the National Academy of Sciences, Vol. 104, Issue 3 https://doi.org/10.1073/pnas.0610202104	journal	January 2007
Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212) Pinto, Donald J. P.; Orwat, Michael J.; Smith, Leon M. Journal of Medicinal Chemistry, Vol. 60, Issue 23 https://doi.org/10.1021/acs.jmedchem.7b01171	journal	November 2017
Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences Bochevarov, Art D.; Harder, Edward; Hughes, Thomas F. International Journal of Quantum Chemistry, Vol. 113, Issue 18 https://doi.org/10.1002/qua.24481	journal	July 2013
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Büller, Harry R.; Bethune, Claudette; Bhanot, Sanjay New England Journal of Medicine, Vol. 372, Issue 3 https://doi.org/10.1056/NEJMoa1405760	journal	January 2015
High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis Meijers, Joost C. M.; Tekelenburg, Winnie L. H.; Bouma, Bonno N. New England Journal of Medicine, Vol. 342, Issue 10 https://doi.org/10.1056/NEJM200003093421004	journal	March 2000
The Halogen Bond Cavallo, Gabriella; Metrangolo, Pierangelo; Milani, Roberto Chemical Reviews, Vol. 116, Issue 4 https://doi.org/10.1021/acs.chemrev.5b00484	journal	January 2016
Novel phenylalanine derived diamides as Factor XIa inhibitors Smith, Leon M.; Orwat, Michael J.; Hu, Zilun Bioorganic & Medicinal Chemistry Letters, Vol. 26, Issue 2 https://doi.org/10.1016/j.bmcl.2015.11.089	journal	January 2016
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity Levinson, Nicholas M.; Boxer, Steven G. Nature Chemical Biology, Vol. 10, Issue 2 https://doi.org/10.1038/nchembio.1404	journal	December 2013
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D. Journal of Medicinal Chemistry, Vol. 58, Issue 11 https://doi.org/10.1021/jm501853m	journal	March 2015
Elevated Factor XI Activity Levels Are Associated With an Increased Odds Ratio for Cerebrovascular Events Yang, David T.; Flanders, Michele M.; Kim, Hyunhee American Journal of Clinical Pathology, Vol. 126, Issue 3 https://doi.org/10.1309/QC259F09UNMKVP0R	journal	September 2006
A Real-World Perspective on Molecular Design: Miniperspective Kuhn, Bernd; Guba, Wolfgang; Hert, Jérôme Journal of Medicinal Chemistry, Vol. 59, Issue 9 https://doi.org/10.1021/acs.jmedchem.5b01875	journal	February 2016
Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group Zhao, Jichen; Zhang, Dehui; Zhang, Weihe Journal of Medicinal Chemistry, Vol. 61, Issue 22 https://doi.org/10.1021/acs.jmedchem.8b01229	journal	October 2018
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species Yang, Wu; Wang, Yufeng; Lai, Amy Journal of Medicinal Chemistry, Vol. 63, Issue 13 https://doi.org/10.1021/acs.jmedchem.0c00464	journal	May 2020
Aldehyde Oxidase: Reaction Mechanism and Prediction of Site of Metabolism Montefiori, Marco; Jørgensen, Flemming Steen; Olsen, Lars ACS Omega, Vol. 2, Issue 8 https://doi.org/10.1021/acsomega.7b00658	journal	August 2017
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors Hauel, Norbert H.; Nar, Herbert; Priepke, Henning Journal of Medicinal Chemistry, Vol. 45, Issue 9 https://doi.org/10.1021/jm0109513	journal	April 2002
Intrinsic Pathway of Coagulation and Thrombosis Grover, Steven P.; Mackman, Nigel Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Issue 3 https://doi.org/10.1161/ATVBAHA.118.312130	journal	March 2019
Tetrahydroquinoline Derivatives as Potent and Selective Factor XIa Inhibitors Quan, Mimi L.; Wong, Pancras C.; Wang, Cailan Journal of Medicinal Chemistry, Vol. 57, Issue 3 https://doi.org/10.1021/jm401670x	journal	January 2014
The hemostatic role of factor XI Puy, Cristina; Rigg, Rachel A.; McCarty, Owen J. T. Thrombosis Research, Vol. 141 https://doi.org/10.1016/S0049-3848(16)30354-1	journal	May 2016
Coagulation factor XI as a novel target for antithrombotic treatment: FXI, target for antithrombotic treatment LÖWenberg, E. C.; Meijers, J. C. M.; Monia, B. P. Journal of Thrombosis and Haemostasis, Vol. 8, Issue 11 https://doi.org/10.1111/j.1538-7836.2010.04031.x	journal	November 2010
A simple convenient method for preparation of difluoromethyl ethers using fluorosulfonyldifluoroacetic acid as a difluorocarbene precursor Chen, Qing-Yun; Wu, Sheng-Wen Journal of Fluorine Chemistry, Vol. 44, Issue 3 https://doi.org/10.1016/S0022-1139(00)82808-0	journal	September 1989
Factor XIa Inhibitors as New Anticoagulants Quan, Mimi L.; Pinto, Donald J. P.; Smallheer, Joanne M. Journal of Medicinal Chemistry, Vol. 61, Issue 17 https://doi.org/10.1021/acs.jmedchem.8b00173	journal	May 2018
CF ₂ H, a Hydrogen Bond Donor Sessler, Chanan D.; Rahm, Martin; Becker, Sabine Journal of the American Chemical Society, Vol. 139, Issue 27 https://doi.org/10.1021/jacs.7b04457	journal	June 2017
Identification of Noncompetitive Protein–Ligand Interactions for Structural Optimization Tosstorff, Andreas; Cole, Jason C.; Taylor, Robin Journal of Chemical Information and Modeling, Vol. 60, Issue 12 https://doi.org/10.1021/acs.jcim.0c00858	journal	October 2020
EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides Goetz, Gilles H.; Philippe, Laurence; Shapiro, Michael J. ACS Medicinal Chemistry Letters, Vol. 5, Issue 10 https://doi.org/10.1021/ml500239m	journal	August 2014

Similar Records

Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group

Journal Article · 2016 · Bioorganic and Medicinal Chemistry · OSTI ID:1347762

Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group

Journal Article · 2016 · Bioorganic and Medicinal Chemistry · OSTI ID:1358846

Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Stu

Journal Article · 2021 · J. Med. Chem. · OSTI ID:1845475

Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exp

Citation Formats

References (59)

Similar Records

Related Subjects